Marc-Henri Galletti is a Managing Director at Longitude Capital, where he focuses on life sciences with emphasis on medical devices, biotechnology, and healthcare. He invests across Series A–D and later, including clinical- and commercial-stage and venture growth, primarily in the United States and Canada. He serves on the board of Murj. Longitude Capital raised $135 million in July 2021. Longitude Capital investments include Vaxcyte, PROCEPT BioRobotics, Mirum Pharmaceuticals, Ceribell, and Somatus. Before Longitude, he was Senior Vice President at Pequot Capital Management and Vice President at Vector Fund Management; earlier roles include Healthcare Equity Analyst at Amerindo Investment Advisors, Associate at J.P. Morgan, and Senior Associate at APM. He attended Northwestern University’s Kellogg School of Management and lives in Menlo Park, California, United States.
Marc-Henri Galletti, Managing Director @ Longitude. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Marc-Henri Galletti from Longitude Capital. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Marc-Henri
Map your path to Marc-Henri instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Marc-Henri
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.